I have two main research interests. First, as a hearth services researcher, I am interested in the public health role of community pharmacists to identify and manage acute and chronic conditions. Our group has conducted some of the first trials of pharmacist prescribing and care in a variety of conditions, including hypertension, diabetes, dyslipidemia and cardiovascular risk reduction. My second interest is providing methodological, data management and biostatistical support for researchers, which we do through EPICORE Centre.
Dr. Ross Tsuyuki received his Doctor of Pharmacy from the State University of New York at Buffalo. He then completed a postdoctoral fellowship in cardiology clinical trials and a Master’s in Health Research Methods at McMaster University.
Leadership and Collaborations:
Dr. Tsuyuki is chair of the Department of Pharmacology and director of the EPICORE Centre (a health research coordinating centre). He is an honorary professor at the University of Waterloo and the University of Otago in New Zealand. Dr. Tsuyuki is the editor-in-chief of the Canadian Pharmacists Journal. He received the Canadian Pharmacists Association’s Canadian Pharmacist of the Year award in 2005. He is a fellow of the Canadian Society of Hospital Pharmacists, the American College of Cardiology and the Canadian Academy of Health Sciences.
Dr. Tsuyuki is actively engaged in training the next generation of health researchers and has mentored more than 50 graduate students and postgraduate trainees. He has received numerous awards for teaching and mentorship.
Dr. Tsuyuki is a health services researcher with a particular focus on chronic disease management in the community. Patients with chronic diseases like hypertension and diabetes see their community pharmacist more frequently than any other health professional. With changing scopes of practice for pharmacists, there is a real potential for identification and better management of patients with chronic conditions like hypertension, diabetes, and high cardiovascular risk – a radical change in primary care. Indeed, our group has conducted some of the first trials of pharmacist prescribing and care in hypertension, diabetes, dyslipidemia, cardiovascular risk, and, recently, in urinary tract infections all of which have shown significant improvements compared to usual care. Implementation of such innovations in primary care are highly supported by patients and are economically dominant (i.e., are more effective than usual care and save money to the health care system).
Dr. Tsuyuki is equally interested in improving the quantity and quality of health research. Through EPICORE Centre (www.epicore.ualberta.ca), he leads a group of dedicated professionals who provide health research services, including consultation on research design, methodology, data management, biostatistics and assistance with research grant preparation. For over 20 years, our group has supported over 400 individual investigators complete over 700 projects. We are also the Consultation and Research Services platform of the Alberta SPOR (Strategy for Patient Oriented Research) SUPPORT Unit, jointly funded by CIHR and Alberta Innovates.
Dr. Tsuyuki has published more than 300 peer-reviewed articles and received the Department of Medicine’s Clinical Investigation Publication Award in 2016. His work has garnered more than $54 million in funding, including support from the Canadian Institutes of Health Research, Heart and Stroke Foundation, Canadian Foundation for Pharmacy Innovation Fund, Sanofi-Aventis Canada Inc., Alberta Innovates, and the University Hospital Foundation- ervier Alberta Innovation in Health Fund.
cardiovascular risk reduction, chronic disease management, diabetes, dyslipidemia, epidemiology, Hypertension, pharmacy practice research, public health